CHOLESTOSOME - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
87158910
Word Mark
CHOLESTOSOME
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2018-10-29
Filing Date
2016-09-01
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2017-01-31
Attorney Name
Law Office Assigned Location Code
N60
Employee Name
STEEL, ALYSSA PALADINO
Statements
Goods and Services
Pharmaceutical preparations for Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of any or all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, and cancers of all types, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis and vaccines and vaccination to prevent or treat infectious diseases and cancer; pharmaceutical preparations, namely, lipid vesicles encapsulating pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of any or all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, and cancers of all types, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis and vaccines and vaccination to prevent or treat infectious diseases and cancer; pharmaceutical preparations, namely, vesicles made of cholesteryl ester and containing pharmaceuticals for use in the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of any or all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, and cancers of all types, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis, and vaccines and vaccination to prevent or treat infectious diseases and cancer
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-09-08
Primary Code
005
Correspondences
Name
R. NEIL SUDOL
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2016-09-05 | NEW APPLICATION ENTERED IN TRAM |
2016-09-08 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2016-12-10 | ASSIGNED TO EXAMINER |
2016-12-14 | EXAMINERS AMENDMENT -WRITTEN |
2016-12-14 | EXAMINERS AMENDMENT E-MAILED |
2016-12-14 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2016-12-14 | EXAMINER'S AMENDMENT ENTERED |
2016-12-19 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2017-01-11 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2017-01-31 | PUBLISHED FOR OPPOSITION |
2017-01-31 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2017-03-28 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2017-05-01 | ASSIGNED TO EXAMINER |
2017-09-01 | TEAS EXTENSION RECEIVED |
2017-09-01 | EXTENSION 1 FILED |
2017-09-01 | EXTENSION 1 GRANTED |
2017-09-05 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2018-03-16 | TEAS EXTENSION RECEIVED |
2018-03-16 | EXTENSION 2 FILED |
2018-03-16 | EXTENSION 2 GRANTED |
2018-03-20 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2018-10-29 | ABANDONMENT - NO USE STATEMENT FILED |
2018-10-29 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |